Phase II trial of ZD0473 as second-line therapy in mesothelioma

This publication has 22 references indexed in Scilit:

• Combined regimen of cisplatin, doxorubicin, and ?-2b interferon in the treatment of advanced malignant pleural mesothelioma
  Cancer, 2001
• ZD0473 phase II monotherapy trial in second-line ovarian cancer
  European Journal Of Cancer, 2001
• Activity of ZD0473 in small-cell lung cancer: an update in patients relapsing after one prior chemotherapy regimen
  European Journal Of Cancer, 2001
• Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B
  Lung Cancer, 2001
• Combination raltitrexed (Tomudex®)–oxaliplatin: a step forward in the struggle against mesothelioma? The Institut Gustave Roussy experience with chemotherapy and chemo-immunotherapy in mesothelioma
  European Journal Of Cancer, 2000
• AMD473
  Drugs of the Future, 1998
• GlutathioneS-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical study
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1996
• Mechanisms of Carcinogenesis and Clinical Features of Asbestos-Associated Cancers
  Cancer Investigation, 1996
• Chemotherapy in malignant mesothelioma: a review
  Cancer Chemotherapy and Pharmacology, 1991
• Malignant Pleural Mesothelioma: Phase II Pilot Study of Ifosfamide and Mesna*
  JNCI Journal of the National Cancer Institute, 1988